• Science & Technology

Drug that targets stem cells could help treat leukaemia

A new drug that can kill specialised stem cells could lead to a new treatment for a type of leukaemia. A new drug that can kill specialised stem cells could lead to a new treatment for a type of leukaemia.

15 September 2016

• Health & Medicine

Immunotherapy drugs show promise in a range of advanced blood cancers

People whose blood cancer has returned after a stem-cell transplant could benefit from immunotherapy treatment, according to a preliminary US trial. People whose blood cancer has returned after a stem-cell transplant could benefit from immunotherapy treatment, according to a preliminary US trial.

14 July 2016

• Health & Medicine

NICE kicks off 'new approach' with leukaemia drug approval

A drug previously considered too expensive for the NHS will now become widely available after NICE agreed a discount A drug previously considered too expensive for the NHS will now become widely available after NICE agreed a discount

8 July 2016

• Charity News

Cancer Research UK researchers honoured by the Queen

Two Cancer Research UK-funded experts have been recognised in the Queen’s Birthday Honours list for their services to science. Two Cancer Research UK-funded experts have been recognised in the Queen’s Birthday Honours list for their services to science.

11 June 2016

• Science & Technology

Acute myeloid leukaemia is 11 different diseases

Researchers studying the genetic make-up of an aggressive blood cancer, AML, have discovered that it exists in at least 11 different forms. Researchers studying the genetic make-up of an aggressive blood cancer, AML, have discovered that it exists in at least 11 different forms.

9 June 2016

• Health & Medicine

Doubling-up on cancer immunotherapy shows promise, but side effects still a challenge

A combination of two immunotherapy drugs outperformed a single drug treatment in patients with a type of advanced lung cancer. A combination of two immunotherapy drugs outperformed a single drug treatment in patients with a type of advanced lung cancer.

4 June 2016

• Health & Medicine

30 years since Chernobyl and 5 years since Fukushima – What have we learnt?

30 years after Chernobyl and five years after Fukushima, we’re taking a look at what has been learnt about radiation-linked cancers. 30 years after Chernobyl and five years after Fukushima, we’re taking a look at what has been learnt about radiation-linked cancers.

26 April 2016

• Science & Technology
• Health & Medicine

Gene editing technology could help engineer better cancer targeting immune cells

We explore how the latest gene editing technology could help our scientists engineer immune cells to precisely target and kill cancer cells. We explore how the latest gene editing technology could help our scientists engineer immune cells to precisely target and kill cancer cells.

15 April 2016

• Health & Medicine

Scientists identify possible double whammy to attack leukaemia

Cancer Research UK scientists have identified a potential double drug combination against B-cell acute lymphoblastic leukaemia. Cancer Research UK scientists have identified a potential double drug combination against B-cell acute lymphoblastic leukaemia.

7 April 2016

• Science & Technology
• Health & Medicine

Immunotherapy cancer ‘cure’ headlines distract from fascinating science

We explore today's headlines about new US research on immunotherapy for blood cancers. We explore today's headlines about new US research on immunotherapy for blood cancers.

16 February 2016

Traces of cancer cells in blood could warn of acute leukaemia relapse

Researchers showed that the presence of leukaemia cells after initial chemotherapy could predict how well a patient subsequently fared. Researchers showed that the presence of leukaemia cells after initial chemotherapy could predict how well a patient subsequently fared.

20 January 2016

• Health & Medicine
• Science & Technology

CAR T cells: Engineering a cancer-fighting immune super soldier

We explore the promise and challenges of research looking to engineer patients' immune cells to fight cancer. We explore the promise and challenges of research looking to engineer patients' immune cells to fight cancer.

19 January 2016